Native Meta creative and exact outbound link observed October 22, 2026. Redirects were followed to the captured public destination. Actual GLP-1 acquisition creative; peptide/sermorelin keyword searches showed no matches. Advertiser claims are source material; activity does not establish performance. No personal, health or payment details were entered.

A long care page develops a direct offer through product quality, treatment comparisons, care steps, customer stories and assessment entry. Compare the creative with the destination and explore the other ads sharing this route.
Selected for its design and offer structure. Ad performance isn’t available in this collection.
The magnifying glass is a great visual device: it literally zooms in on the fine print, so the viewer discovers the catch the same way they would on a real offer. The top half is designed in grey like a generic competitor ad, and the bottom half switches to Eden's green with the vial, so the contrast between them and us is clear before reading a word. The answer line, meds included and no asterisk, is short and quotable, and the ad headline matches the $129 on the card.
The post copy has a typo that undercuts the whole ad: it says $12 every dose with no hidden fees, while the card and headline say $129. In an ad about honest pricing, a wrong number in the copy invites exactly the doubt it's trying to remove. Fix the copy to $129 before anything else. After that, a reason to act now (the page's lifetime price guarantee) would give the price-checker a reason to start this month.
It recreates a competitor offer and reveals its catch, so the viewer feels they've discovered it themselves.
It answers the catch directly in one short line, in Eden's own colors.
It's meant to restate the price and add proof, though the first line's typo contradicts the card.
$129 a month with medication included, framed against a $39 first month that excludes medication; the copy mistakenly says $12 every dose.
The ad lands on Eden's GLP-1 affiliate page, a focused landing page whose hero lists tirzepatide at $129/mo (matching the card) beside semaglutide at $99/mo, under an all-inclusive price line. The plan inclusions section further down is where meds included gets spelled out, which is the right follow-up for an ad about what's left out. The free assessment is the single next step.
Eden's GLP-1 affiliate page is a long, focused landing page that opens on semaglutide at $99/mo and tirzepatide at $129/mo with a free assessment, then covers quality, treatment, care steps, stories and FAQs. All 16 Eden ads in the Fluid library link here, mostly price comparisons plus creator and doctor videos.
The headline, three benefits, both monthly prices and the free assessment button answer what it costs and how to start, with Trustpilot and member-count proof alongside.
It covers where the medication comes from and who oversees care, answering whether a low price means cutting corners.
It explains the problem and how the treatment is meant to work, answering why someone would consider it at all.
It compares treatment options so the visitor can work out which one fits before starting the assessment.
It walks through the steps from assessment to ongoing care, answering what happens after the click.
It shows stories from customers, answering whether people like the visitor have used the service.
It lists what the plan includes and repeats the assessment entry, answering what the monthly price covers right before asking again.
It handles remaining questions and the safety and compounding disclosures, answering the last objections before signing up.
Read the full breakdown of this page
One of 16 Eden ads in the Fluid Inspiration Library, captured from the Meta Ad Library on Oct 22, 2026. We record that an ad ran publicly, not how it performed.